American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism

TL Ortel, I Neumann, W Ageno, R Beyth… - Blood …, 2020 - ashpublications.org
In August 2022, these guidelines were reviewed by an expert work group convened by ASH.
Review included limited searches for new evidence and discussion of the search results …

Interventional therapies for acute pulmonary embolism: current status and principles for the development of novel evidence: a scientific statement from the American …

J Giri, AK Sista, I Weinberg, C Kearon, DJ Kumbhani… - Circulation, 2019 - Am Heart Assoc
Pulmonary embolism (PE) represents the third leading cause of cardiovascular mortality.
The technological landscape for management of acute intermediate-and high-risk PE is …

Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report

SM Stevens, SC Woller, LB Kreuziger, H Bounameaux… - Chest, 2021 - Elsevier
Background This is the 2nd update to the 9th edition of these guidelines. We provide
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …

A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism …

G Piazza, B Hohlfelder, MR Jaff, K Ouriel… - Cardiovascular …, 2015 - jacc.org
Objectives This study conducted a prospective, single-arm, multicenter trial to evaluate the
safety and efficacy of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis, using …

Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism

N Kucher, P Boekstegers, OJ Müller, C Kupatt… - Circulation, 2014 - Am Heart Assoc
Background—In patients with acute pulmonary embolism, systemic thrombolysis improves
right ventricular (RV) dilatation, is associated with major bleeding, and is withheld in many …

Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis

S Chatterjee, A Chakraborty, I Weinberg, M Kadakia… - Jama, 2014 - jamanetwork.com
Importance Thrombolytic therapy may be beneficial in the treatment of some patients with
pulmonary embolism. To date, no analysis has had adequate statistical power to determine …

Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice …

C Kearon, EA Akl, AJ Comerota, P Prandoni… - Chest, 2012 - Elsevier
Background This article addresses the treatment of VTE disease. Methods We generated
strong (Grade 1) and weak (Grade 2) recommendations based on high-quality (Grade A) …

Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis

C Marti, G John, S Konstantinides… - European heart …, 2015 - academic.oup.com
Aim Thrombolytic therapy induces faster clot dissolution than anticoagulation in patients with
acute pulmonary embolism (PE) but is associated with an increased risk of haemorrhage …

[HTML][HTML] Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double‐blind, placebo …

JA Kline, KE Nordenholz, DM Courtney… - Journal of thrombosis …, 2014 - Elsevier
Background Acute pulmonary embolism (PE) can worsen quality of life due to persistent
dyspnea or exercise intolerance. Objective Test if tenecteplase increases the probability of a …

Late outcomes of pulmonary embolism: the post-PE syndrome

AK Sista, FA Klok - Thrombosis research, 2018 - Elsevier
Abstract The post-Pulmonary Embolism (post-PE) syndrome is being increasingly
recognized as a long-term consequence of PE. Its most severe manifestation, chronic …